The effectiveness and economics of bacteriological control of blood components



Cite item

Full Text

Abstract

The efficiency of screening for bacterial contamination of the components of blood and the possibilities of its improvement were estimated. The total volume of stored blood in Russia is more than 1.5 million liters annually. No more than 10 liters are rejected for bacterial contamination and more than 10 tons of blood is used for bacteriological control.
The standing instruction for controlling of the sterility of preserved blood, its components, preparations, preserved bone marrow, blood substitutes, and preserving solutions (1995) lays down that the blood and its components stored in plastic containers are to be selectively controlled.

References

  1. Инструкция по контролю стерильности консервированной крови, ее компонентов, препаратов, консервированного костного мозга, кровезаменителей и консервирующих растворов (утв. Первым зам. Министра здравоохранения РФ 29.05.1995). - М., 1995.
  2. Приказ Минздрава России от 20 нояб. 1996 г. № 384 "Об утверждении отраслевой статистической отчетности". - М., 1996.
  3. Приказ Минздрава России от 25.11.2002 г. № 363 "Об утверждении инструкции по применению компонентов крови". - М., 2002.
  4. Хальфин Р. А. Законодательное обеспечение донорства крови: проблемы и перспективы // Главврач. - 2007. - № 4. - С. 12-16.
  5. AABB. 2005. The 2004 Nationwide Blood Collection and Utilization Survey / http: // www.hhs.gov/bloodsafety/ 2005NBCUS.pdf
  6. Benjamin R. J., Kline L., Dy B. A. et al. Bacterial contamination of whole blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross // Transfusion. - 2008. - Vol. 48, N 11. - P. 2348-2355.
  7. Brecher M. E. Bacterial contamination of blood products // Rossi's Principles of Transfusion medicine / Ed. T. L. Simon. - 3-rd Ed. - Baltimore, 2002. - P. 789.
  8. Brecher M. E., Hay S. N. Bacterial contamination of blood components // Clin. Microbiol. Rev. - 2005. - Vol. 18, N 1. - P. 195-204.
  9. Chen C. L., Yu J. C., Holme S. et al. Detection of bacteria in stored red cell products using a culture-based bacterial detection system // Transfusion. - 2008 - Vol. 48, N 8. - P. 1550- 1557.
  10. Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components.
  11. Engelfriet C/ P., Reesink H. W., Blajchman M. A. et al. Bacterial contamination of blood components // Vox Sang. - 2000. - Vol. 78, N 1. - P. 59-67.
  12. FDA. 2007. Fatalities Reported to FDA following Blood Collection and Transfusion. Annual Summary for Fiscal Years 2005 and 2006 / http://www. fda.gov/cher/blood/fatail0506
  13. Gibson T., Norris W. Skin fragments removed by injection needles // Lancet. - 1998. - Vol. 2. - P. 983-985.
  14. Guide for the preparation, Use and Quality assurance of Blood and Blood Components. - 14-th Ed. - Strasbourg, 2008.
  15. Holme S., McAlister M. B., Ortolano G. A. et al. Enhancement of a culture-based bacterial detection system (eBDS) for platelet products based on measurement of oxygen consumption // Transfusion. - 2005. - Vol. 45, N 6. - P. 984-993.
  16. Knutson F., Alfonso R., Dupuis K. et al. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function // Vox Sang. - 2000. - Vol. 78, N 4. - P. 209-216.
  17. Kuehnert M. J., Roth V. R., Haley N. R. et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000 // Transfusion. - 2001. - Vol. 41, N 12. - P. 1493- 1499.
  18. Larsen C. P., Ezligini F., Hermansen N. O., Kjeldsen-Kragh J. Six years' experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of falsenegative results // Vox Sang. - 2005. - Vol. 88, N 2. - P. 93- 97.
  19. Lee J. 1999. U. S. Food and Drug Administration. Presented at the FDA/CBER Workshop on Bacterial Contamination of Platelets / www.FDA. gov/CBER/minutes/bact092499.pdf
  20. Li J., de Korte D., Woolum M. D. et al. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen- reduction tecinology-treated apheresis platelet products // Vox Sang. - 2004. - Vol. 87, N 2. - P. 82-90.
  21. Lozano M., Galan A, Mazzara R. et al. Leukoreduced buffs' coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions // Transfusion. - 2007. - Vol. 47, N 4. - P. 666-671
  22. McCullough J., Vesole D. H., Benjamin P. J. et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial // Blood. - 2004. - Vol. 104, N 5. - P. 1534-1541.
  23. McDonald C. P. Bacterial risk reduction by improved donor arm disinfection, diversion and bacterial screening // Transfus. Med. - 2006. - Vol. 16, N 6. - P. 381-396.
  24. Ness P., Braine H., King K. et al. Single-donor platelets reduce the risk of septic platelet transfusion reactions // Transfusion. - 2001. - Vol. 41, N 7. - P. 857-861.
  25. Pelletier J. P. R., Transue S., Snyder E. L. Pathogen inactivation techniques // Best Pract. Res. Clin. Haematol. - 2006. - Vol. 19, N 1. - P. 205-242.
  26. Perez P., Salmi L. R., Folléa C. et al. Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study // Transfusion. - 2001. - Vol. 41, N 7. - P. 862-872.
  27. Picker S. M., Steisel A., Gathof B. S. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irrffadiated units // Transfusion. - 2008. - Vol. 48, N 8. - P. 1685- 1692.
  28. Rhame F. S., Root R. K., MacLowry J. D. et al. Salmonella septicemia from platelet transfusions. Study of an outbreak traced to a hematogenous carrier of Salmonella cholerae-suis // Ann. Intern. Med. - 1973. - Vol. 78, N 5. - P. 633-641.
  29. Roth V. R., Arduino M. J., Nobiletti J. et al. Transfusion-related sepsis due to Serratia liquefaciens in the United States // Transfusion. - 2000. - Vol. 40, N 8. - P. 931-935.
  30. Schmidt M., Karakassopoulos A., Burkhart J. et al. Comparison of three bacterial detection methods under routine conditions // Vox Sang. - 2007. - Vol. 92, N 1. - P. 15-21.
  31. SHOT. 2002. Serious Hazards of Transfusion. SHOT report for 2000-2001. (Cumulative data 01/10/1995-30/09/2002)/http:// www.shot.demon.co.uk/toc.htm
  32. Theakston E. P., Morris A. J., Streat S. J. et al. Transfusion transmitted Yersinia enterocolitica infection in New Zealand // Aust. N. Z. J. Med. - 1997. - Vol. 27, N 1. - P. 62-67.
  33. Tipple M. A., Bland L. A., Murphy J. J. et al. Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica // Transfusion. - 1990. - Vol. 30, N 3. - P. 207-213.
  34. Tolksdorf F., Mohr H., Walker W. H., Muller T. H. Theraflex UV platelets performance of a new method for pathogen inactivation of plasma-reduced platelet concentrates // Vox Sang. - 2008. - Vol. 95, Suppl. 1. - P. 309.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Eco-vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 014448 от 08.02.1996. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80652 от 15.03.2021 .


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies